이용시간안내 : 평일 09:00 - 18:00
상세정보
- 상세정보
Plotkin's vaccines [eBook]
Orenstein, Walter A.
- 책이미지
-
![Plotkin's vaccines [eBook] 표지이미지](https://iph.futurenuri.co.kr/dl_image/IMG/01/000000000487/INTROIMAGE/000000000487_01.JPG)
- 도서 상세정보
- 서평쓰기
- 책이미지
-
QRcode
- QRcode 사용방법
-
QRcode 사용방법
- QR코드 정의
- 사각형의 가로세로 격자무늬에 다양한 정보를 담고 있는 2차원(매트릭스)형식의 코드로 스마트폰으로 QR코드를 스캔하면 각종 정보를 제공 받을 수 있습니다.
- QR코드 인식프로그램
- 스마트폰 마켓에 들어가면 'QR코드 스캔 프로그램'을 검색해 무료 어플을 다운받아 사용하시면 됩니다.
- 도서정보 QR코드 이용하기
- 도서 상세정보에서 QR코드를 스캔하면, 모바일 웹페이지로 연결되어 해당 도서의 상세정보 및 소장정보 등을 확인 할 수 있습니다.
| 자료유형 | 단행본 |
|---|---|
| 개인저자 | Orenstein, Walter A. Offit, Paul A. Edwards, Kathryn M. Plotkin, Stanley A. |
| 단체저자명 | ClinicalKey eBook |
| 서명/저자사항 | Plotkin's vaccines [eBook] / [edited by] Walter A. Orenstein, Paul A. Offit, Kathryn M. Edwards, Stanley A. Plotkin |
| 판사항 | 8th ed. |
| 발행사항 | Philadelphia, PA:ClinicalKey eBook,2023 |
| 형태사항 | 1 online resource:color illustrations |
| ISBN | 9780323790581 9780323790598(eBook) |
| 서지주기 | Includes bibliographical references and index. |
| 일반주제명 | Vaccines. Vaccination. Immunization Programs. |
| 비통제주제어 | Infectious Diseases |
| 바로가기 | URL
: PDF 다운로드: ClinicalKey 오른쪽 위 Register→개인 ID 생성 후 가능 |
목차 일부
1.A Short History of Vaccination
2.Vaccine Immunology
3.Non-specific Effects of Vaccines
4.Correlates of Protection
5.The Vaccine Industry
6.Vaccine Manufacturing
7.Evolution of Adjuvants Across...
2.Vaccine Immunology
3.Non-specific Effects of Vaccines
4.Correlates of Protection
5.The Vaccine Industry
6.Vaccine Manufacturing
7.Evolution of Adjuvants Across...
목차 전체
1.A Short History of Vaccination
2.Vaccine Immunology
3.Non-specific Effects of Vaccines
4.Correlates of Protection
5.The Vaccine Industry
6.Vaccine Manufacturing
7.Evolution of Adjuvants Across the Centuries
8.Vaccine Additives and Manufacturing Residuals in Vaccines Licensed in the United States
9.Passive Immunization
10.General Immunization Practices
11.Human Adenovirus Vaccines
12.Anthrax Vaccines *
13..Biodefense Vaccines, Vaccines for Emerging Infectious Diseases, and Coalition for Epidemic Preparedness Innovations (CEPI)
14.Cancer Vaccines
15.Cholera Vaccines
16.Combination Vaccines
17.Coronavirus Vaccines
18.Cytomegalovirus Vaccines
19.Dengue Vaccines
20.Vaccines Against Diarrhea Caused by Noncholera Bacteria
21.Diphtheria Toxoid
22.Ebola Vaccines
23.Nonpolio Enteroviruses
24.Epstein–Barr Virus Vaccines
25.Haemophilus influenzae Type b Vaccines
26.Hepatitis A Vaccines
27.Hepatitis B Vaccines
28.Hepatitis C Vaccines
29.Hepatitis E Vaccines
30.Herpes Simplex Virus Vaccines
31.Human Immunodeficiency Virus Vaccines
32.Human Papillomavirus Vaccines
33.Inactivated and Recombinant Influenza Vaccines
34.Influenza Vaccine—Live
35.Japanese Encephalitis Vaccines
36.Lyme Disease Vaccines—The Journey Continues
37.Malaria Vaccines
38.Measles Vaccines
39.Meningococcal Capsular Group A, C, W, and Y Conjugate Vaccines
40.Meningococcal Vaccines Directed at Capsular Group B
41.Mumps Vaccines
42.Noninfectious Disease Vaccines
43.Norovirus
44.Parasitic Disease Vaccines
45.Pertussis Vaccines
46.Plague Vaccines
47.Pneumococcal Conjugate Vaccine and Pneumococcal Common Protein Vaccines
48.Pneumococcal Polysaccharide Vaccines
49.Poliovirus Vaccine—Inactivated
50.Poliovirus Vaccine–Live
51.Lyssaviruses and Rabies Vaccines
52.Respiratory Syncytial Virus Vaccines and Monoclonal Antibodies
53.Rotavirus Vaccines
54.Rubella Vaccines
55.Smallpox and Vaccinia
56.Staphylococcus aureus Vaccines
57.Streptococcus Group A Vaccines
58.Streptococcus Group B Vaccines
59.Tetanus Toxoid
60.Tickborne Encephalitis Vaccines
61.Tuberculosis Vaccines
62.Typhoid Fever Vaccines
63.Varicella Vaccines
64.Yellow Fever Vaccine
65.Zika Virus Vaccines
66.Zoster Vaccines
67.Technologies for Making New Vaccines
68.Genetic-Based Vaccine Vectors
69.Technologies to Improve Immunization
70.Vaccination of Immunocompromised Hosts
71.Vaccines for International Travel
72.Vaccines for Healthcare Personnel
73.Vaccination of Pregnant Women
74.Immunization in the United States
75.Immunization in Europe
76.Immunization and Vaccine-Preventable Diseases in the Asia-Pacific Region
77.Immunization in Low- and Middle-Income Countries
78.Community Protection
79.Economic Analyses of Vaccine Policies
80.Regulation and Testing of Vaccines in the US
81.Regulation of Vaccines in Europe
82.Regulation of Vaccines in Low- and Middle-Income Countries
83.Vaccine Safety
84.Vaccine Hesitancy and Behavioral Factors Associated With Vaccine Uptake
85.Legal Issues
86.Ethics
2.Vaccine Immunology
3.Non-specific Effects of Vaccines
4.Correlates of Protection
5.The Vaccine Industry
6.Vaccine Manufacturing
7.Evolution of Adjuvants Across the Centuries
8.Vaccine Additives and Manufacturing Residuals in Vaccines Licensed in the United States
9.Passive Immunization
10.General Immunization Practices
11.Human Adenovirus Vaccines
12.Anthrax Vaccines *
13..Biodefense Vaccines, Vaccines for Emerging Infectious Diseases, and Coalition for Epidemic Preparedness Innovations (CEPI)
14.Cancer Vaccines
15.Cholera Vaccines
16.Combination Vaccines
17.Coronavirus Vaccines
18.Cytomegalovirus Vaccines
19.Dengue Vaccines
20.Vaccines Against Diarrhea Caused by Noncholera Bacteria
21.Diphtheria Toxoid
22.Ebola Vaccines
23.Nonpolio Enteroviruses
24.Epstein–Barr Virus Vaccines
25.Haemophilus influenzae Type b Vaccines
26.Hepatitis A Vaccines
27.Hepatitis B Vaccines
28.Hepatitis C Vaccines
29.Hepatitis E Vaccines
30.Herpes Simplex Virus Vaccines
31.Human Immunodeficiency Virus Vaccines
32.Human Papillomavirus Vaccines
33.Inactivated and Recombinant Influenza Vaccines
34.Influenza Vaccine—Live
35.Japanese Encephalitis Vaccines
36.Lyme Disease Vaccines—The Journey Continues
37.Malaria Vaccines
38.Measles Vaccines
39.Meningococcal Capsular Group A, C, W, and Y Conjugate Vaccines
40.Meningococcal Vaccines Directed at Capsular Group B
41.Mumps Vaccines
42.Noninfectious Disease Vaccines
43.Norovirus
44.Parasitic Disease Vaccines
45.Pertussis Vaccines
46.Plague Vaccines
47.Pneumococcal Conjugate Vaccine and Pneumococcal Common Protein Vaccines
48.Pneumococcal Polysaccharide Vaccines
49.Poliovirus Vaccine—Inactivated
50.Poliovirus Vaccine–Live
51.Lyssaviruses and Rabies Vaccines
52.Respiratory Syncytial Virus Vaccines and Monoclonal Antibodies
53.Rotavirus Vaccines
54.Rubella Vaccines
55.Smallpox and Vaccinia
56.Staphylococcus aureus Vaccines
57.Streptococcus Group A Vaccines
58.Streptococcus Group B Vaccines
59.Tetanus Toxoid
60.Tickborne Encephalitis Vaccines
61.Tuberculosis Vaccines
62.Typhoid Fever Vaccines
63.Varicella Vaccines
64.Yellow Fever Vaccine
65.Zika Virus Vaccines
66.Zoster Vaccines
67.Technologies for Making New Vaccines
68.Genetic-Based Vaccine Vectors
69.Technologies to Improve Immunization
70.Vaccination of Immunocompromised Hosts
71.Vaccines for International Travel
72.Vaccines for Healthcare Personnel
73.Vaccination of Pregnant Women
74.Immunization in the United States
75.Immunization in Europe
76.Immunization and Vaccine-Preventable Diseases in the Asia-Pacific Region
77.Immunization in Low- and Middle-Income Countries
78.Community Protection
79.Economic Analyses of Vaccine Policies
80.Regulation and Testing of Vaccines in the US
81.Regulation of Vaccines in Europe
82.Regulation of Vaccines in Low- and Middle-Income Countries
83.Vaccine Safety
84.Vaccine Hesitancy and Behavioral Factors Associated With Vaccine Uptake
85.Legal Issues
86.Ethics